Contact a Lawyer Now
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 11, 2020 to file lead plaintiff applications in a securities class action lawsuit against Inovio Pharmaceuticals (NasdaqGS: INO).
Inovio and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On March 9, 2020, pre-market, Citron Research published a statement highlighting the Company’s “ludicrous and dangerous claim that they designed a [COVID-19] vaccine in 3 hours” and calling for an SEC investigation into the claims.
On this news, the price of Inovio’s shares plummeted damaging investors, closing at $5.70 per share on March 10, 2020, a drop of 71%.
If you purchased shares of Inovio and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (email@example.com), or fill out the form on this page.
The case is The case is McDermid v. Inovio Pharmaceuticals, Inc., et al., 2:20-cv-01402., 2:20-cv-01402.
Click here to read the first filed complaint.